Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2010
09/23/2010CA2755778A1 Peptides modulating the activity of igf-1 and the applications of said peptides
09/23/2010CA2755722A1 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
09/23/2010CA2755686A1 Methods and compositions for bi-specific targeting of cd19/cd22
09/23/2010CA2755639A1 Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof
09/23/2010CA2755509A1 Agents and methods for tissue repair and regeneration
09/23/2010CA2755436A1 Peptides for inhibiting igf-1
09/23/2010CA2755133A1 Selective and potent peptide inhibitors of kv1.3
09/23/2010CA2754950A1 Terminally-functionalized conjugates and uses thereof
09/22/2010EP2230320A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
09/22/2010EP2230317A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
09/22/2010EP2230307A1 Neutrokine alpha
09/22/2010EP2230300A1 Polypeptide having enhanced effector function
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230253A1 A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
09/22/2010EP2230245A1 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
09/22/2010EP2229952A1 Plasma anti-diabetic NUCB2 peptide (pladin and nesfatin-1n) and uses thereof
09/22/2010EP2229951A1 Methods for the treatment or prevention of systemic sclerosis
09/22/2010EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
09/22/2010EP2229473A2 Identification of toxin ligands
09/22/2010EP2229440A2 Recombinant elastase proteins and methods of manufacturing and use thereof
09/22/2010EP2229432A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria
09/22/2010EP2229408A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
09/22/2010EP2229405A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases
09/22/2010EP2229404A1 Combination enzyme therapy for gastric digestion of dietary gluten in celiac sprue patients
09/22/2010EP2229403A1 Recovery of hydrophobic peptides from oils
09/22/2010EP2229400A1 Advantageous salts of mu-opiate receptor peptides
09/22/2010EP2229185A2 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
09/22/2010EP2229180A1 Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan
09/22/2010EP2229179A2 Sldlr in viral hepatitis
09/22/2010EP2229137A1 Topical compositions containing desthiobiotin and its derivatives and a method of treating skin
09/22/2010EP2007415B1 Combination of an anti-edb fibronectin domain antibody/il2 fusion protein and a further small molecule
09/22/2010EP1890721B1 Compositions and methods for treating cardiac conditions
09/22/2010EP1725576B1 Positive modulator of bone morphogenic protein-2
09/22/2010EP1554301B1 Dengue vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1 and 2.
09/22/2010EP1450850B1 Method of administering a thymosin alpha 1 peptide
09/22/2010EP1436313B1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
09/22/2010EP1401853B1 Modulators of pharmacological agents
09/22/2010EP1371663B1 Anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process
09/22/2010EP1335938B1 Apolipoprotein construct
09/22/2010EP1239872B1 Enzyme treatment for digestive tract infections
09/22/2010EP1194449B1 Inhibitors of memapsin 2 and use thereof
09/22/2010CN1893961B Biologically active blood serum obtained by electroshock
09/22/2010CN1612746B Use of HEPCIDIN as a regulator of iron homeostasis
09/22/2010CN1545422B Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred
09/22/2010CN101842486A Immunology treatment for biofilms
09/22/2010CN101842386A Truncated GLP-1 derivatives and their therapeutical use
09/22/2010CN101842385A Food material for inhibiting the formation of osteoclast
09/22/2010CN101842118A Use of hydrophobin polypeptides as penetration enhancers
09/22/2010CN101842113A Immune response inducer
09/22/2010CN101842112A Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium
09/22/2010CN101842111A Selective cytopheresis devices and related methods thereof
09/22/2010CN101842110A Recombinant transferrin mutants
09/22/2010CN101842109A Peptides derivatized with A-B-C-D- and their therapeutical use
09/22/2010CN101842108A Use of g-csf for the treatment of stroke
09/22/2010CN101842107A Antimicrobial peptide, compositions , and methods of use
09/22/2010CN101842083A LH liquid formulations
09/22/2010CN101842082A Peptide slow-release formulations
09/22/2010CN101842026A Bone-strengthening food material
09/22/2010CN101842009A Treatment of lung cancer
09/22/2010CN101838654A Ceratopteris pteridoides gene for resisting human immunologic deficiency disease toxoprotein congeners, and preparation method and application thereof
09/22/2010CN101838650A Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody
09/22/2010CN101838330A Sterilized/permeability-strengthened protein-human acid fibroblast growth factor fusion protein, preparation method and application thereof
09/22/2010CN101838329A Anti-angiogenesis fusion protein
09/22/2010CN101838328A Anti-vegf antibodies
09/22/2010CN101838327A Human IL-15 subtype protein and preparation method and application thereof
09/22/2010CN101838326A Use of the CATHELICIDIN LL-37 and derivatives thereof for wound healing
09/22/2010CN101838323A Anti-platelet thrombolysin and preparation method thereof
09/22/2010CN101838313A Mimic short peptide 9B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838312A Mimic short peptide 12B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838311A Mimic short peptide 7B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838310A Basic fibroblast growth factor epitope simulative peptide T3 and application thereof
09/22/2010CN101838309A Solid-phase synthesis of momordica charantia MC-JJ0102 polypeptide analogue under microwave irradiation and application thereof
09/22/2010CN101838307A K2 polypeptide synthesis product and application thereof
09/22/2010CN101838306A K4 polypeptide synthesis product and application thereof
09/22/2010CN101838305A T2 peptide synthesis product and application thereof
09/22/2010CN101837130A Polyethylene glycol-dipeptide-antitumour drug complex and use thereof
09/22/2010CN101837124A Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
09/22/2010CN101837121A Use of Ulinastatin for treating acute hepatic failure
09/22/2010CN101837120A Method for orally administering parathyroid hormone (PTH)
09/22/2010CN101837119A Method for preparing interleukin-11 semi-finished product solution, and products thereof
09/22/2010CN101837118A Compound chicken colibacillosis resisting veterinary drug preparation
09/22/2010CN101837117A Application of B cell epitope peptide from tetanus exotoxin fragment C
09/22/2010CN101837116A Liver-protecting and alcoholism-relieving product using Saccharomyces cerevisiae as main material
09/22/2010CN101411878B Method for anchoring growth factor on material with biodegradability
09/22/2010CN101234089B Alkaline fibroblast growth factor liposome vaccine and preparation method and application thereof
09/22/2010CN101181626B Transfer factor capsule and preparation method thereof
09/22/2010CN101180042B Conjugate of biomacromolecule with bioreductive and preparative method thereof
09/22/2010CN101177454B IL-18 mutant polypeptide as well as preparation and usage
09/22/2010CN101153052B Uridine peptide antibiotic, pharmaceutically acceptable salt, producing method and uses thereof
09/22/2010CN101002931B Ubenimex tablet and its preparing method
09/21/2010US7799902 Receptor coupling agents and compositions thereof
09/21/2010US7799901 capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 (mediators of receptor toxicity) protein
09/21/2010US7799898 Human transferase family members and uses thereof
09/21/2010US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/21/2010US7799896 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening
09/21/2010US7799833 System and method for the pretreatment of the endplates of an intervertebral disc
09/21/2010US7799794 Treatment for cardiovascular disease
09/21/2010US7799769 Daily dosage topical gel of an androgen with safe female-appropriate dose for side effect reduction; also for decreased sexual desire
09/21/2010US7799762 Functionally substituted amino acids, having fatty acid chains bound through amidification of the amine functional groups of dipeptide like compounds, one end bears a functional side chain and other side neutral or charged acid
09/21/2010US7799761 Pharmaceutical compositions including low dosages of desmopressin
1 ... 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 ... 3163